Article Text
Therapeutics
Randomised controlled trial
Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects
Statistics from Altmetric.com
Footnotes
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.